TAYDのニュース
Taylor Devices Is A Great Company, But Trades At An Expensive Price (NASDAQ:TAYD) 2023/02/01 15:57:39 Seeking Alpha
Taylor Devices specializes in shock-absorbing devices for construction and aerospace uses, among others. See here for the business and TAYD stock outlook.
Taylor Devices: Pristine Balance Sheet Growth Potential Remain In Place (Rating Downgrade) 2023/01/16 12:15:00 Seeking Alpha
Taylor Devices is a well-established company with a high level of expertise in the shock and vibration control field. See why we are a hold on TAYD stock.
Taylor Devices GAAP EPS of $0.45, revenue of $10.5M (NASDAQ:TAYD) 2022/12/30 14:40:10 Seeking Alpha
Taylor Devices press release (NASDAQ:TAYD): Q2 GAAP EPS of $0.45.Revenue of $10.5M (+35.5% Y/Y).
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday''s Mid-Day Session 2022/12/29 18:14:27 Benzinga
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH ) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ: QTNT ) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ: BXRX ) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ: PALI ) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection. Nuwellis, Inc. (NASDAQ: NUWE ) shares climbed 40.5% to $12.88. Nuwellis announced an exclusive U.S. license and distribution agreement for SeaStar Medical Holding’s Selective Cytopheretic Device (SCD) for acute kidney injury (AKI) in children.
VIEW, REKR and AP among industrial movers 2022/12/29 17:56:23 Seeking Alpha
Gainers:Expion360 Inc. (XPON) +24%.Taylor Devices, Inc
Taylor Devices: Pristine Balance Sheet Growth Potential Remain In Place (Rating Downgrade) 2023/01/16 12:15:00 Seeking Alpha
Taylor Devices is a well-established company with a high level of expertise in the shock and vibration control field. See why we are a hold on TAYD stock.
Taylor Devices GAAP EPS of $0.45, revenue of $10.5M (NASDAQ:TAYD) 2022/12/30 14:40:10 Seeking Alpha
Taylor Devices press release (NASDAQ:TAYD): Q2 GAAP EPS of $0.45.Revenue of $10.5M (+35.5% Y/Y).
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday''s Mid-Day Session 2022/12/29 18:14:27 Benzinga
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH ) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ: QTNT ) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ: BXRX ) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ: PALI ) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection. Nuwellis, Inc. (NASDAQ: NUWE ) shares climbed 40.5% to $12.88. Nuwellis announced an exclusive U.S. license and distribution agreement for SeaStar Medical Holding’s Selective Cytopheretic Device (SCD) for acute kidney injury (AKI) in children.
VIEW, REKR and AP among industrial movers 2022/12/29 17:56:23 Seeking Alpha
Gainers:Expion360 Inc. (XPON) +24%.Taylor Devices, Inc
Taylor Devices Stock Gains On Solid 35% Revenue Growth In Q2 2022/12/29 16:08:30 Benzinga
Taylor Devices Inc (NASDAQ: TAYD ) reported second-quarter FY23 sales growth of 35% year-on-year, to $10.49 million. Net earnings for Q2 totaled $1.6 million versus $0.7 million … Full story available on Benzinga.com
Taylor Devices GAAP EPS of $0.45, revenue of $10.5M (NASDAQ:TAYD) 2022/12/30 14:40:10 Seeking Alpha
Taylor Devices press release (NASDAQ:TAYD): Q2 GAAP EPS of $0.45.Revenue of $10.5M (+35.5% Y/Y).
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday''s Mid-Day Session 2022/12/29 18:14:27 Benzinga
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH ) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ: QTNT ) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ: BXRX ) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ: PALI ) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection. Nuwellis, Inc. (NASDAQ: NUWE ) shares climbed 40.5% to $12.88. Nuwellis announced an exclusive U.S. license and distribution agreement for SeaStar Medical Holding’s Selective Cytopheretic Device (SCD) for acute kidney injury (AKI) in children.
VIEW, REKR and AP among industrial movers 2022/12/29 17:56:23 Seeking Alpha
Gainers:Expion360 Inc. (XPON) +24%.Taylor Devices, Inc
Taylor Devices Stock Gains On Solid 35% Revenue Growth In Q2 2022/12/29 16:08:30 Benzinga
Taylor Devices Inc (NASDAQ: TAYD ) reported second-quarter FY23 sales growth of 35% year-on-year, to $10.49 million. Net earnings for Q2 totaled $1.6 million versus $0.7 million … Full story available on Benzinga.com
TAYLOR DEVICES ANNOUNCES SECOND QUARTER AND SIX-MONTH RESULTS 2022/12/29 13:52:00 Benzinga
NORTH TONAWANDA, N.Y. , Dec. 29, 2022 /PRNewswire/ -- Taylor Devices, Inc. (NASDAQ SmallCap: "TAYD") announced today that it had 2 nd quarter sales of $10,497,366 , up 35% from last year''s 2 nd quarter sales of $7,757,986 while sales for the 1 st six months were $19,588,065 , up 30% from last year''s 1 st six-month sales of $15,065,723 . Net earnings for the 2 nd quarter were $1,559,508 , up significantly from last year''s 2 nd quarter net earnings of $659,804 with net earnings for the 1 st six months finishing at $2,561,879 , also up significantly from last year''s net earnings for the 1 st six months of $841,681 . "Our FY23 2nd quarter and 1st half sales finished significantly better than last year''s levels respectively with all three of our customer product groups; Aerospace/Defense, Structural and Industrial, sales levels improved year-on-year," stated Tim Sopko , CEO. He continued, "This also sets a new high record for sales in the first six months of a fiscal year concurrent with sales in the quarter exceeding the $9 million threshold for the 3 rd consecutive quarter, another first for our company." He further commented, "Earnings for the 2 nd quarter and 1 st half are also significantly improved over last year''s levels both in total dollars as well as a percentage of sales; 136% better for the quarter and 204% better for the 1 st half." He continued, "This profitable growth is largely due to our team''s disciplined adherence to our growth strategies as well as their excellent work on continuous improvements …